Association of insurance status and age with cervical cancer stage at diagnosis: National cancer database, 2000-2007

American Journal of Public Health

Volumn 102, Issue 9, 2012, Pages 1782-1790

  Fedewa, Stacey A ^a   Cokkinides, Vilma ^a   Virgo, Katherine S ^a   Bandi, Priti ^a   Saslow, Debbie ^b   Ward, Elizabeth M ^a  

^a Department of Research ^*  (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; MEDICAID; MEDICARE; MIDDLE AGED; PATHOLOGY; REGISTER; RISK; STATISTICS; UNITED STATES; UTERINE CERVIX TUMOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INSURANCE, HEALTH; MEDICAID; MEDICARE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; RISK; SEER PROGRAM; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84865692485     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300532     Document Type: Review

References (57)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4):212-236.
2. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008;113(10 suppl):2855-2864.
3. Altekruse SFKC, Krapcho M, Neyman N, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
4. Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of latestage cervical cancer. Arch Fam Med. 2000;9(5):439-445.
5. Free K, Roberts S, Bourne R, et al. Cancer of the cervix-old and young, now and then. Gynecol Oncol. 1991;43(2):129-136.
6. Singh GK, Miller BA, Hankey BF, Edwards BK. Persistent area socioeconomic disparities in U. S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer. 2004;101(5):1051-1057. (Pubitemid 39100440)
7. Virnig BA, Baxter NN, Habermann EB, Feldman RD, Bradley CJ. A matter of race: early-versus late-stage cancer diagnosis. Health Aff (Millwood). 2009;28(1):160-168.
8. Mitchell JB, McCormack LA. Time trends in late-stage diagnosis of cervical cancer. Differences by race/ethnicity and income. Med Care. 1997;35(12):1220-1224. (Pubitemid 127457072)
9. Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health. 1991;81(5):646-649.
10. Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening. Cancer. 1991;67(5):1454-1459.
11. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93(22):1704-1713. (Pubitemid 33130259)
12. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer; 116(20):4872-4881.
13. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health. 1994;84(10):1598-1604. (Pubitemid 24323416)
14. Commission on Cancer. National Cancer Database (NCDB); 2010. Available at: http://www.facs.org/cancer/ncdb/index.html. Accessed October 20, 2009.
15. American Joint Commission on Cancer. AJCCC Cancer Staging Manual. 6th ed. Chicago, IL: Springer; 2002.
16. US Census Bureau. Census regions and divisions of the United States. 2009. Available at: http://www.census. gov/geo/www/us-regdiv.pdf. Accessed July 15, 2010.
17. US Census Bureau. Census 2000. Available at: http://www.census.gov/main/ www/cen2000.html. Accessed Novemeber 1, 2010.
18. Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med. 2008;65(7):481, 501-506.
19. Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY. Comparison of Commission on Cancerapproved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009;27(25):4177-4181.
20. North American Association of Central Cancer Registries. CINA+ cancer incidence rates in North America. 2010. Available at: http://www.cancer-rates. info/naaccr. Accessed March 25, 2011.
21. * Stat Database: Incidence-SEER 17 Regs Research, Data + Hurricane Katrina Impacted Louisiana Cases, Nov. 2009 Sub (1973-2007 varying)-Linked To County Attributes-Total U. S., 1969-2007 Counties, released April 2010, based on the November 2009 submission. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2010.
22. National Center for Health Statistics. National Health Interview Survey (NHIS), Public Use Data Release, NHIS Survey Description. Hyattsville, MD: Centers for Disease Control and Prevention; 2000, 2005.
23. Kirschner B, Poll S, Rygaard C, Wahlin A, Junge J. Screening history in women with cervical cancer in a Danish population-based screening program. Gynecol Oncol. 2011;120(1):68-72.
24. Gök M, Rozendaal L, Berkhof J, Visser O, Meijer CJL, van Kemenade FJ. Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases. Br J Cancer. 2011;104(4):685-692.
25. Subramaniam A, Fauci JM, Schneider KE, et al. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era? J Low Genit Tract Dis. 2011;15(2):110-113.
26. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675-683. (Pubitemid 40812631)
27. Ventura SAJ, Mosher W. Estimated Pregnancy Rates by Outcome for the United States, 1990-2004. Hyattsville, MD: Center for Disease Control and Prevention; 2008.
28. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153(9):865-874. (Pubitemid 32378620)
29. Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: National Center for Health Statistics; 2010.
30. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907. (Pubitemid 47371147)
31. Harlan LC, Bernstein AB, Kessler LG. Cervical cancer screening: who is not screened and why? Am J Public Health. 1991;81(7):885-890.
32. Janerich DT, Hadjimichael O, Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995;85(6):791-794.
33. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10):810-819. (Pubitemid 30317797)
34. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med. 2000;31(3):261-270.
35. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care. 1998;36(3):257-270.
36. Berk ML, Schur CL. Access to care: how much difference does Medicaid make? Health Aff (Millwood). 1998;17(3):169-180. (Pubitemid 128466149)
37. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by Race/Ethnicity and Socioeconomic Status. CA Cancer J Clin. 2004;54(2):78-93. (Pubitemid 38519418)
38. Nash D, Chan C, Horowitz D, Vlahov D. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002. J Womens Health (Larchmt). 2007;16(1):46-56.
39. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85(7):566-570. (Pubitemid 23110931)
40. Yabroff KR, Freedman A, Brown ML, Ballard-Barbash R, McNeel T, Taplin S. Trends in abnormal cancer screening results in the United States of America. J Med Screen. 2007;14(2):67-72. (Pubitemid 47067759)
41. Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev. 2003;60:294-331. (Pubitemid 36993502)
42. Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med. 1999;8(6):510-514.
43. Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R. Factors in quality care-the case of follow-up to abnormal cancer screening tests-problems in the steps and interfaces of care. J Natl Cancer Inst Monogr. 2010;2010(40):58-71.
44. Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care. Womens Health Issues. 2010;20(6):400-405.
45. Daley E, Alio A, Anstey EH, Chandler R, Dyer K, Helmy H. Examining barriers to cervical cancer screening and treatment in Florida through a socio-ecological lens. J Community Health. 2011;36(1):121-131.
46. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342-362. (Pubitemid 35446606)
47. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer. 2000;88(10):2283-2289. (Pubitemid 30247128)
48. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among White, Hispanic, and African American women: 1996-2000. Cancer. 2007;109(2 suppl):348-358. (Pubitemid 46106219)
49. Kaiser Family Foundation. Racial and Ethnic Disparities in Women's Health Care Coverage and Access to Care: Findings From the 2001 Kaiser Women's Health Survey. Washington, DC: Kaiser Family Foundation; 2004.
50. Bansal S, Lewin SN, Burke WM, et al. Sarcoma of the cervix: natural history and outcomes. Gynecol Oncol. 2010;118(2):134-138.
51. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among White women and Black women in the United States for 1976-2000. Cancer. 2004;100(5):1035- 1044. (Pubitemid 38232621)
52. Brinton LA, Tashima KT, Lehman HF, et al. Epidemiology of cervical cancer by cell type. Cancer Res. 1987;47(6):1706-1711. (Pubitemid 17044508)
53. Tangka FK, O'Hara B, Gardner JG, et al. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control. 2010;21(7):1081-1090.
54. Centers for Disease Conrtol and Prevention. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). 2010. Available at: http://www.cdc.gov/cancer/nbccedp/data/summaries/national-aggregate.htm. Accessed March 24, 2011.
55. Bradley CJ, Given CW, Roberts C. Late stage cancers in a Medicaid-insured population. Med Care. 2003;41(6):722-728.
56. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287(16):2120-2129. (Pubitemid 34437347)
57. US Preventative Task Force. Screening for Cervical Cancer US Preventative Task Force; 2003. Available at: http://www.uspreventiveservicestaskforce.org/ uspstf/uspscerv. htm. Accessed April 3, 2011.